SCHEMBL13508451

SCHEMBL13508451

C(=C(c1ccc2ccccc2c1)c1ccc2ccccc2c1)c1ccc(N(c2ccc(C=C(c3ccc4ccccc4c3)c3ccc4ccccc4c3)cc2)c2ccc(C=C(c3ccc4ccccc4c3)c3ccc4ccccc4c3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
ESR1 P03372 3/20 0.43
ESR2 Q92731 2/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
EGFR P00533 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
JAK1 P23458 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508382 0.95 ESR1 (0.45) PTGS1PTGS2ESR1ESR2KDM4E
SCHEMBL13380719 0.88 ESR1 (0.44) PTGS2ESR1ESR2KDM4EALDH1A1
SCHEMBL13508399 0.84 ESR1 (0.36) PTGS2ESR1MEN1CYP3A4KMT2A
SCHEMBL2964613 0.84 CES2 (0.47) PTGS1PTGS2ESR1ESR2CES2
SCHEMBL13380720 0.83 ESR1 (0.37) PTGS1PTGS2ESR1ESR2KDM4E
SCHEMBL13380721 0.82 KMO (0.36) PTGS2ESR1ALDH1A1MAPTMAPK1
SCHEMBL14003792 0.82 PTGS2 (0.44) PTGS2ESR1ALDH1A1MAPTHPGD
SCHEMBL11988518 0.82 ALDH1A1 (0.48) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL11988086 0.82 AKR1C3 (0.38) PTGS2ESR1ESR2CES2CES1
SCHEMBL13992021 0.80 ESR1 (0.57) PTGS2ESR1ESR2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761962-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2010-02-03 EP disclosed
US-20090159874-A1 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2009-06-25 US disclosed
US-20090159874-A1 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090159874-A1 Organic electroluminescent devices LEF1, NCS1, CRY1 PTGS1 2375/4885PTGS2 3216/4885ESR1 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.